LENZ Therapeutics (LENZ) Interest Coverage Ratio (2020)
LENZ Therapeutics (LENZ) reported Interest Coverage Ratio of 64.6 for Q2 2020.
LENZ Therapeutics (LENZ) Interest Coverage Ratio (2020) Analysis & Trends
LENZ Therapeutics (LENZ) has 1 years of Interest Coverage Ratio data on file, last reported at 64.6 in Q2 2020.
- Interest Coverage Ratio for Q2 2020 came in at 64.6, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was 1137.35 (changed N/A YoY), and the FY2020 annual result was 337.5, changed N/A from the prior year.
- Interest Coverage Ratio was little changed at 64.6 in Q2 2020 per LENZ's latest filing.
- Over five years, Interest Coverage Ratio peaked at 64.6 in Q2 2020 and troughed at 64.6 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | LENZ Therapeutics | 192.19 Mn | 192.19 Mn | 825,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -64.60 |